| Literature DB >> 32175008 |
Jiuzhou Chen1, Yu Wang1, Xuan Guo1, Deming Rao1, Wenjuan Zhou1, Ping Zheng1, Jibin Sun1, Yanhe Ma1.
Abstract
BACKGROUND: 5-Aminolevulinic acid (5-ALA) is a promising biostimulant, feed nutrient, and photodynamic drug with wide applications in modern agriculture and therapy. Considering the complexity and low yield of chemical synthesis methods, bioproduction of 5-ALA has drawn intensive attention recently. However, the present bioproduction processes use refined glucose as the main carbon source and the production level still needs further enhancement.Entities:
Keywords: 5-Aminolevulinic acid; Cassava bagasse; Corynebacterium glutamicum; Metabolic engineering; Renewable bioresource
Year: 2020 PMID: 32175008 PMCID: PMC7063817 DOI: 10.1186/s13068-020-01685-0
Source DB: PubMed Journal: Biotechnol Biofuels ISSN: 1754-6834 Impact factor: 6.040
Bioproduction of 5-ALA by engineered strains via C4 biosynthetic pathway from different substrates
| Strain and strategy | Main substrates | Titer (g/L) | Productivity (g/L h) | Reference |
|---|---|---|---|---|
| Overexpression of hemA from | Succinate, glycine | 5.2 | 0.43 | [ |
| Overexpression of | Glucose, succinate, glycine | 5.2 | 0.32 | [ |
| Overexpression of | Glucose, succinate, glycine | 6.6 | 0.24 | [ |
| Overexpression of | Glucose, succinate, glycine, xylose | 7.3 | 0.24 | [ |
| Overexpression of | Glucose, succinate, glycine | 6.3 | 0.26 | [ |
| Overexpression of | Glucose, succinate, glycine | 9.4 | 0.43 | [ |
| Overexpression of | Glycerol, succinate, glycine | 8.8 | 0.24 | [ |
| Overexpression of | Glucose | 2.8 | 0.06 | [ |
| Overexpression of | Glucose, glycine | 7.5 | 0.23 | [ |
| Overexpression of | Glucose, glycine | 7.6 | 0.095 | [ |
| Overexpression of | Glucose, glycine | 14.7a | 0.92a | |
| Moderate overexpression of | Glucose, glycine | 16.3 | 0.42 | This study |
| Cassava bagasse hydrolysate, glycine | 18.5 | 0.47 | ||
aA two-stage fermentation was employed. The cultivation time of the first step for cell growth was not reported in that study, and thus the productivity of the second step for 5-ALA production was shown
Fig. 1Schematic illustration of the bioproduction of 5-ALA by metabolically engineered C. glutamicum from cheap renewable bioresources. PEP, phosphoenolpyruvate; hemA, 5-aminolevulinate synthase (ALAS) encoding gene; ppc, phosphoenolpyruvate carboxylase (PPC) encoding gene
Fig. 2Screening of ALASs from different sources for 5-ALA production. RpHemA, hemA from R. palustris, expressed using P; RpHemO, hemO from R. palustris, expressed using P; RsHemA, hemA from R. sphaeroides, expressed using P; RpHemA, hemA from R. palustris, expressed using P; RpHemA, hemA from R. palustris, expressed using P. Dark grey bars, 5-ALA production level; green bars, ALAS activity in crude extract. Strains with different ALASs were cultivated in shake flasks with modified M9 medium. The titer of 5-ALA at 36 h is shown. Cells were collected at the same time and lysed for ALAS activity assay. The reaction mixture contained 100 mM Tris–HCl (pH 7.5), 200 mM glycine, 0.2 mM succinyl-CoA, 0.1 mM pyridoxal phosphate (PLP) and 20 µg crude extract. After proceeding at 37 ℃ for 10 min, the reaction was terminated by the addition of 10% (v/v) trichloroacetic acid. Concentration of 5-ALA in the supernatant was determined. Error bars indicate standard deviations from three parallel experiments
Fig. 3Fine-tuning of ALAS expression for 5-ALA production. a Effects of regulating ALAS expression via RBS engineering on 5-ALA production. b Correlation between ALAS activity in crude extract and 5-ALA production level. The x-axis shows mean of ALAS activities in crude extract measured by ALAS formation rate of three parallel experiments. Strains were cultivated in shake flasks with modified M9 medium. OD600nm value, 5-ALA titer and yield at 36 h are shown. Cells were collected at the same time and lysed for ALAS activity assay. The reaction mixture contained 100 mM Tris–HCl (pH 7.5), 200 mM glycine, 0.2 mM succinyl-CoA, 0.1 mM pyridoxal phosphate (PLP) and 20 µg crude extract. After proceeding at 37 ℃ for 10 min, the reaction was terminated by the addition of 10% (v/v) trichloroacetic acid. Concentration of 5-ALA in the supernatant was determined. Error bars indicate standard deviations from three parallel experiments
Fig. 4Fine-tuning of PPC expression for 5-ALA production. a Effects of regulating PPC expression via RBS engineering on 5-ALA production. b Correlation between PPC activity in crude extract and 5-ALA production level. The x-axis shows mean of PPC activities in crude extract measured by NADH oxidation rate of three parallel experiments. Strains were cultivated in shake flasks with modified M9 medium. OD600nm value, 5-ALA titer and yield at 36 h are shown. Cells were collected at the same time and lysed for PPC activity assay. The PPC activity was determined by a coupling reaction catalyzed by malate dehydrogenase at 30 ℃. The reaction mixture contained 100 mM Tris–HCl (pH 7.5), 2 mM phosphoenolpyruvate, 10 mM NaHCO3, 10 mM MnSO4, 0.1 mM NADH, 20% (v/v) glycerol, 1.6 U malate dehydrogenase, and 20 µg crude extract. The activity was assayed spectrophotometrically by monitoring the decrease in absorbance of NADH at 340 nm. Error bars indicate standard deviations from three parallel experiments
Fig. 5Fed-batch fermentation for 5-ALA production from glucose using strains CA and CA1P4. Black filled labels represent strain CA and green open labels represent strain CA1P4. Square, OD600nm; circle, glucose consumption; triangle, glycine consumption; diamond, 5-ALA; star, lactate. Dotted line represents simulated growth curve based on OD600nm data. Cultivation was performed in 5-L bioreactors with fermentation medium. IPTG (0.1 mM) and glycine (4 g/L) were added when OD600nm reached approximately 40 to induce gene expression and 5-ALA biosynthesis. Glucose and glycine were continuously fed into the bioreactor during the fermentation. The pH was controlled at 6.5 initially and switched to 6.0 at 15 h. The dissolved O2 was maintained at 30% initially and switched to 10% at 18 h
Fig. 6Fed-batch fermentation for 5-ALA production using different carbon sources. Black square, OD600nm; green circle, 5-ALA. Dotted line represents simulated growth curve based on OD600nm data. Cultivation was performed in 5-L bioreactors with fermentation medium. IPTG (0.1 mM) and glycine (4 g/L) were added when OD600nm reached approximately 40 to induce gene expression and 5-ALA biosynthesis. Sugar solution and glycine were continuously fed into the bioreactor during the fermentation. The pH was controlled at 6.5 initially and switched to 6.0 at 15 h. The dissolved O2 was maintained at 30% initially and switched to 10% at 18 h
Strains and plasmids used in this study
| Strain or plasmid | Descriptiona | Reference or source |
|---|---|---|
| Strain | ||
| | F− | Invitrogen |
| | Wild type | ATCC |
| CA | This study | |
| CO | This study | |
| CA-Rs | This study | |
| CA1 | This study | |
| CA2 | This study | |
| CA3 | This study | |
| CA4 | This study | |
| CA1P | This study | |
| CA1P1 | This study | |
| CA1P2 | This study | |
| CA1P3 | This study | |
| CA1P4 | This study | |
| CA1P5 | This study | |
| CA1P6 | This study | |
| Plasmid | ||
| pET28a-RS-hemA | pET28a harboring | [ |
| pEC-XK99E | [ | |
| pRpA | pEC-XK99E harboring | This study |
| pRpO | pEC-XK99E harboring | This study |
| pRsA | pEC-XK99E harboring | This study |
| pRpAtuf | pRpA derivative, | This study |
| pRpAsod | pRpA derivative, | This study |
| pRpA1 | pRpA derivative, RBS-1 of RpHemA replaced with RBS-2 | This study |
| pRpA2 | pRpA derivative, RBS-1 of RpHemA replaced with RBS-3 | This study |
| pRpA3 | pRpA derivative, RBS-1 of RpHemA replaced with RBS-4 | This study |
| pRpA4 | pRpA derivative, RBS-1 of RpHemA replaced with RBS-5 | This study |
| pRpA1P | pRpA1 derivative, harboring | This study |
| pRpA1P1 | pRpA1P derivative, RBS-1 of | This study |
| pRpA1P2 | pRpA1P derivative, RBS-1 of | This study |
| pRpA1P3 | pRpA1P derivative, RBS-1 of | This study |
| pRpA1P4 | pRpA1P derivative, RBS-1 of | This study |
| pRpA1P5 | pRpA1P derivative, RBS-1 of | This study |
| pRpA1P6 | pRpA1P derivative, RBS-1 of | This study |
aKanR represents resistance to kanamycin. RBSs used in this study are shown in Additional file 1: Table S2